1259 related articles for article (PubMed ID: 25762624)
1. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
Humphries B; Yang C
Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
[TBL] [Abstract][Full Text] [Related]
2. Review of miR-200b and cancer chemosensitivity.
Feng B; Wang R; Chen LB
Biomed Pharmacother; 2012 Sep; 66(6):397-402. PubMed ID: 22795796
[TBL] [Abstract][Full Text] [Related]
3. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
5. The microRNA-200 family: still much to discover.
Senfter D; Madlener S; Krupitza G; Mader RM
Biomol Concepts; 2016 Dec; 7(5-6):311-319. PubMed ID: 27837593
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
7. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
8. MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.
Lu YF; Zhang L; Waye MM; Fu WM; Zhang JF
Exp Cell Res; 2015 May; 334(1):173-82. PubMed ID: 25857406
[TBL] [Abstract][Full Text] [Related]
9. The miR-15a/16 gene cluster in human cancer: A systematic review.
Liu T; Xu Z; Ou D; Liu J; Zhang J
J Cell Physiol; 2019 May; 234(5):5496-5506. PubMed ID: 30246332
[TBL] [Abstract][Full Text] [Related]
10. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
[TBL] [Abstract][Full Text] [Related]
11. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
12. MiR-205 in cancer: an angel or a devil?
Qin AY; Zhang XW; Liu L; Yu JP; Li H; Wang SZ; Ren XB; Cao S
Eur J Cell Biol; 2013 Feb; 92(2):54-60. PubMed ID: 23279926
[TBL] [Abstract][Full Text] [Related]
13. The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment.
Gao Y; Feng B; Han S; Zhang K; Chen J; Li C; Wang R; Chen L
Cell Physiol Biochem; 2016; 38(2):427-48. PubMed ID: 26828359
[TBL] [Abstract][Full Text] [Related]
14. miR-197: A novel biomarker for cancers.
Wang DD; Chen X; Yu DD; Yang SJ; Shen HY; Sha HH; Zhong SL; Zhao JH; Tang JH
Gene; 2016 Oct; 591(2):313-9. PubMed ID: 27320730
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
16. MiR-106a: Promising biomarker for cancer.
Pan YJ; Zhuang Y; Zheng JN; Pei DS
Bioorg Med Chem Lett; 2016 Nov; 26(22):5373-5377. PubMed ID: 27780637
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
19. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
[TBL] [Abstract][Full Text] [Related]
20. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
